Figure 4.
An additive combined effect of budesonide and pioglitazone in inhibition of cell proliferation of human lung cancer cells. (A) Budesonide inhibits the proliferation of human non-small lung cancer cells in a dose- and time-dependent manner. (B) Combination (Comb) of budesonide (Bud) and pioglitazone (Pio) additively inhibits the proliferation of human non-small lung cancer cells.